Clinical Study | Office of Clinical Research

Rapastinel As An Added Therapy In Major Depressive Disorder

Posted Date: May 15, 2019

Investigator: Erik Nelson
Type of Study: Drug

The purpose of this research study is to help understand how well experimental Rapastinel works to treat Major Depressive Disorder (MDD). ?Experimental? means that the study drug is currently being tested. It is not approved by the U.S. Food and Drug Administration (FDA). We will look at how well

Criteria:

To Be Considered For Enrollment Into The Study You Must: ? Be Between 18 And 65 Years Of Age ? G

Keywords:

Ketamine, Major Depressive Dis, Depression

For More Information:

Jade Lord
513-558-4997
lordje@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List